The concurrent exposure to aluminium and fructose induces liver injury in rats: Protection by monoammonium glycyrrhizinate. (30th January 2020)

• Record Type: Journal Article
• Authors: Zakaria, Sarah; Hasan, Rehab A.; Mahmoud, Mona F.; El Fayoumi, Hassan M.; Mahmoud, Amr A. A.
• Is Part Of: Clinical and experimental pharmacology and physiology. Volume 47:Number 5(2020)
• Page Start: 809
• Page End: 820
• Publication Date: 2020-01-30
• Subjects: aluminium chloride -- fructose -- insulin resistance -- liver injury -- monoammonium glycyrrhizinate -- silymarin -- toll‐like receptor 4; Clinical pharmacology -- Periodicals; Pharmacology, Experimental -- Periodicals; Physiology, Experimental -- Periodicals; Physiology, Pathological -- Periodicals; 615.1
• DOI: 10.1111/1440-1681.13257
• Languages: English
• ISSNs: 0305-1870

Abstract

Abstract: Aluminium is a ubiquitous element that occurs naturally in the soil making human exposure to it unavoidable. It is implicated in the aetiology of different neurodegenerative diseases and can induce liver injury. In addition, insulin resistance (IR) plays an essential role in the pathogenesis and the progression of liver disorders. The increased consumption of fructose contained in soft drinks and western pattern diet results in IR that along with the wide distribution of aluminium make the concurrent exposure conceivable and increase the risk of liver injury. Therefore, the present study explores the hepatotoxic effects of aluminium and fructose administered concurrently and evaluates the possible protection by monoammonium glycyrrhizinate (MAG). Liver injury was induced by the administration of aluminium chloride (34 mg/kg/d) plus 10% (w/v) fructose in drinking water. Male rats were treated with either MAG (40 mg/kg/d) or silymarin (SIL, 100 mg/kg/d). The concurrent administration of aluminium and fructose (FRUAL) induced liver injury manifested as a significant elevation of serum liver enzymes activities, bilirubin level, and prothrombin time, as well as reduction of albumin level. On the other hand, the administration of MAG improved the FRUAL‐induced aberrations of liver function tests and hepatic cytoarchitecture. We assume that the MAG‐induced suppression of oxidative stress, toll‐like receptor 4 pathway activation, inflammation, and apoptosis might play a crucial role in the hepatoprotective effect of MAG in this model. Intriguingly, the hepatoprotective effect MAG against FRUAL‐induced liver injury surpasses that of the gold standard SIL, suggesting MAG as a better alternative to SIL.